Trial Profile
An open-label study of Sofosbuvir-Containing Regimens for for HCV Genotype 2 or 3 Infected Patients Who Failed Prior Sofosbuvir Plus Ribavirin Therapy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Peginterferon (Primary) ; Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 18 Dec 2015 New trial record